Y. Mark Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Y. Mark Hong has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Alan T. Paciorek
Department of Urology, University of California-San Francisco, San Francisco, CA 94143, USA
1 shared publicationBrian Linder
Department of Urology, George Washington University, Washington, District of Columbia
1 shared publicationDouglas E. Sutherland
Department of Urology, Multicare Urology of Tacoma, Tacoma, Washington
1 shared publicationJason D. Engel
Department of Urology, George Washington University, Washington, District of Columbia
1 shared publicationJim C. Hu
Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA
1 shared publicationKevin R. Loughlin
1 shared publication
Latest Publications
- 1 May 2010
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 28 (3) , 268-273
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE™
- 1 May 2010
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 28 (3) , 268-273
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE™
- 1 March 2010
- Published by SAGE Publications in Journal of Endourology
- Vol. 24 (3) , 473-477
“Learning Curve” May Not Be Enough: Assessing the Oncological Experience Curve for Robotic Radical Prostatectomy
The use of robot-assisted laparoscopic radical prostatectomy (RALP) is widespread in the community. A definitive RALP “learning curve” has not been defined and existing learning curves do not account for urologists without prior advanced laparoscopic skills. Therefore, an easily evaluable metric, the “oncological experience curve,” would be clinically useful to all urologists performing RALP. Positive surgical margin (PSM) status for all subjects undergoing RALP during the first 4 years of a single surgeon's experience was assessed. Univariate and multivariate analyses and logistic regression identified predictors of PSM creation and their correlation with surgeon case volume. The oncological experience curve was defined as the case point at which only pT2 stage, not surgeon volume (and thus surgeon inexperience), predicted PSM in the logistic regression. A total of 469 consecutive subjects comprised our cohort. Overall pT2 and pT3 PSM rates were 20% and 40%, respectively. Preoperative prostate-specific antigen, pathologic stage, and year of surgery were associated with PSM occurrence. Pathologic stage exclusively correlated to PSM in pT2 specimens for the first time during the fourth year, after 290 subjects had been treated. pT2 PSM rate before and after Case 290 was 25% and 10%, respectively (p < 0.001). The oncological experience curve is a clinically meaningful measure to evaluate the RALP learning curve for non–fellowship-trained urologists. The oncological experience curve may be much longer than the previously reported learning curves. Surgeons should consider whether they can build enough experience to minimize suboptimal oncological outcomes before embarking on or continuing a RALP program.
- 1 March 2010
- Published by SAGE Publications in Journal of Endourology
- Vol. 24 (3) , 473-477
“Learning Curve” May Not Be Enough: Assessing the Oncological Experience Curve for Robotic Radical Prostatectomy
The use of robot-assisted laparoscopic radical prostatectomy (RALP) is widespread in the community. A definitive RALP “learning curve” has not been defined and existing learning curves do not account for urologists without prior advanced laparoscopic skills. Therefore, an easily evaluable metric, the “oncological experience curve,” would be clinically useful to all urologists performing RALP. Positive surgical margin (PSM) status for all subjects undergoing RALP during the first 4 years of a single surgeon's experience was assessed. Univariate and multivariate analyses and logistic regression identified predictors of PSM creation and their correlation with surgeon case volume. The oncological experience curve was defined as the case point at which only pT2 stage, not surgeon volume (and thus surgeon inexperience), predicted PSM in the logistic regression. A total of 469 consecutive subjects comprised our cohort. Overall pT2 and pT3 PSM rates were 20% and 40%, respectively. Preoperative prostate-specific antigen, pathologic stage, and year of surgery were associated with PSM occurrence. Pathologic stage exclusively correlated to PSM in pT2 specimens for the first time during the fourth year, after 290 subjects had been treated. pT2 PSM rate before and after Case 290 was 25% and 10%, respectively (p < 0.001). The oncological experience curve is a clinically meaningful measure to evaluate the RALP learning curve for non–fellowship-trained urologists. The oncological experience curve may be much longer than the previously reported learning curves. Surgeons should consider whether they can build enough experience to minimize suboptimal oncological outcomes before embarking on or continuing a RALP program.